Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Parke-Davis
Detroit, Michigan, United Statespfizer.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Once the world’s largest pharmaceutical company and a pioneer in drug standardization, clinical trials, and vaccine development. Notable products included Dilantin for epilepsy, the first bacterial vaccine in the US, Benadryl antihistamine, Chloromycetin antibiotic, oral contraceptives, PCP and ketamine anesthetics. The company was acquired by Warner-Lambert in 1970 and became part of Pfizer after Pfizer’s acquisition of Warner-Lambert in 2000[1][5][6].
- Therapeutic areas
- EndocrinologyNeurologyInfectious Diseases
- Modalities
- Small molecules (historically)Vaccines/biologics (historically)
- Industry
- Pharma
02
Partnerships
Daiichi Sankyo Co. (co-development of Rezulin)[1]Glaxo Wellcome (co-development of Rezulin)[1]
Beyond the preview
Go deeper on Parke-Davis.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Parke-Davis.